Atlas Trials

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours

Clinical trial NCT02788565 · COMPLETED

Trial details

NCT number
NCT02788565
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroenteropancreatic Neuroendocrine Tumours
Start date
2016-03-01
Primary completion
2016-10-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.